Wednesday, June 17, 2020 6:44:02 PM
I had 3 million shares and have dumped them all.
Great product - terrible management.
The money was never in the external product.
It was always in the internal product for surgery.
Which is unique.
Norchi had some curveballs thrown his way and always struck out.
Plan A was to get the external approved and then a licensing deal to pay for the internal process.
Great plan. But unfortunately Plan A doesn't always work out.
So you need to go to Plan B. And he never did.
There were 2 big mistakes.
First - when they filed the CE application years ago as a drug and not a medical device. And it was rejected........
Well they shouldn't have said.."Well we will move on to something else."
They should have spent 6 weeks re-doing the application.
Then........
It either gets accepted or rejected.
If it gets approved.....Well great.
If it doesn't....well at least they would know why.
And the stuff could have been fixed years ago.
Second - after FDA approval 18 months ago......
Well. When 6 months went by with no licensing deal.
They should have just bitten the bullet. And diluted.
The internal trials could be done by now.
and the FDA and CE applications submitted and under review.
Instead.....
At some point next year they will start the internal trials.
And it could be 2 years before everything is done and approved.
With possibly 800 million shares outstanding...
If they can get new investors.
I don't buy the conspiracy they have intentionally dogged it.
And just exist to collect a salary.
It is a great product.
But it was always the internal product that had the value.
And Management was never able to move from Plan A to Plan B.
Or maybe even Plan C.
And that is what you need to be able to do to take a penny stock across the finish line.
Recent ARTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 09:00:11 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM